Li D, Lan X, Xu L, Zhou S, Luo H, Zhang X
Front Immunol. 2025; 16:1552010.
PMID: 40066456
PMC: 11891355.
DOI: 10.3389/fimmu.2025.1552010.
Doonan B, Radwan F, Banik N, Haque A
Biomedicines. 2025; 13(2).
PMID: 40002858
PMC: 11853664.
DOI: 10.3390/biomedicines13020445.
Andrianto A, Sudiana I, Suprabawati D
Iran J Pathol. 2024; 19(1):67-74.
PMID: 38864081
PMC: 11164303.
DOI: 10.30699/IJP.2023.2004468.3126.
Xiang Y, Liu X, Wang Y, Zheng D, Meng Q, Jiang L
Front Immunol. 2024; 15:1366260.
PMID: 38655260
PMC: 11035781.
DOI: 10.3389/fimmu.2024.1366260.
Lin Z, Zou S, Wen K
Front Immunol. 2024; 14:1255443.
PMID: 38288118
PMC: 10822999.
DOI: 10.3389/fimmu.2023.1255443.
Aberrant R-loop-mediated immune evasion, cellular communication, and metabolic reprogramming affect cancer progression: a single-cell analysis.
Zhang S, Liu Y, Sun Y, Liu Q, Gu Y, Huang Y
Mol Cancer. 2024; 23(1):11.
PMID: 38200551
PMC: 10777569.
DOI: 10.1186/s12943-023-01924-6.
The Regression of Glioblastoma Multiforme is Time Dependent in the Wild-type Rat Xenograft Model.
Nematollahi-Mahani S, Ganjalikhan-Hakemi S, Abdi Z
Basic Clin Neurosci. 2023; 14(2):263-272.
PMID: 38107534
PMC: 10719980.
DOI: 10.32598/bcn.2021.3370.1.
The impact of the gut microbiome on tumor immunotherapy: from mechanism to application strategies.
Guo C, Kong L, Xiao L, Liu K, Cui H, Xin Q
Cell Biosci. 2023; 13(1):188.
PMID: 37828613
PMC: 10571290.
DOI: 10.1186/s13578-023-01135-y.
Isorhamnetin Influences the Viability, Superoxide Production and Interleukin-8 Biosynthesis of Human Colorectal Adenocarcinoma HT-29 Cells In Vitro.
Greifova H, Tokarova K, Jambor T, Stefunkova N, Spevakova I, Dupak R
Life (Basel). 2023; 13(9).
PMID: 37763324
PMC: 10533024.
DOI: 10.3390/life13091921.
HNRNPC promotes collagen fiber alignment and immune evasion in breast cancer via activation of the VIRMA-mediated TFAP2A/DDR1 axis.
Lian B, Yan S, Li J, Bai Z, Li J
Mol Med. 2023; 29(1):103.
PMID: 37528369
PMC: 10394847.
DOI: 10.1186/s10020-023-00696-5.
The impact of the Hedgehog signal pathway on the tumor immune microenvironment of gastric adenocarcinoma by integrated analysis of scRNA-seq and RNA-seq datasets.
Zhong J, Sun Y, Wu S, Zhang T, Yang J, He Y
Funct Integr Genomics. 2023; 23(3):258.
PMID: 37526746
DOI: 10.1007/s10142-023-01187-w.
Angiogenic signaling pathways and anti-angiogenic therapy for cancer.
Liu Z, Chen H, Zheng L, Sun L, Shi L
Signal Transduct Target Ther. 2023; 8(1):198.
PMID: 37169756
PMC: 10175505.
DOI: 10.1038/s41392-023-01460-1.
TRAIL in the Treatment of Cancer: From Soluble Cytokine to Nanosystems.
Zeinabad H, Szegezdi E
Cancers (Basel). 2022; 14(20).
PMID: 36291908
PMC: 9600485.
DOI: 10.3390/cancers14205125.
Neoadjuvant Chemotherapy Improves the Immunosuppressive Microenvironment of Bladder Cancer and Increases the Sensitivity to Immune Checkpoint Blockade.
Luo H, Liu G, Jian D, Liang D, Li X, Zhong L
J Immunol Res. 2022; 2022:9962397.
PMID: 35915657
PMC: 9338739.
DOI: 10.1155/2022/9962397.
Stemness Correlates Inversely with MHC Class I Expression in Pediatric Small Round Blue Cell Tumors.
Muller L, Kschischo M, Vokuhl C, Stahl D, Gutgemann I
Cancers (Basel). 2022; 14(15).
PMID: 35892842
PMC: 9331651.
DOI: 10.3390/cancers14153584.
TLR/WNT: A Novel Relationship in Immunomodulation of Lung Cancer.
Martin-Medina A, Ceron-Pisa N, Martinez-Font E, Shafiek H, Obrador-Hevia A, Sauleda J
Int J Mol Sci. 2022; 23(12).
PMID: 35742983
PMC: 9224119.
DOI: 10.3390/ijms23126539.
Pattern of F-18 FDG Uptake in Colon Cancer after Bacterial Cancer Therapy Using Engineered : A Preliminary Study.
Chong A, Nguyen D, Kim H, Chung J, Min J
Mol Imaging. 2022; 2022:9222331.
PMID: 35517712
PMC: 9042370.
DOI: 10.1155/2022/9222331.
Identification of a combined apoptosis and hypoxia gene signature for predicting prognosis and immune infiltration in breast cancer.
Ren X, Cui H, Wu J, Zhou R, Wang N, Liu D
Cancer Med. 2022; 11(20):3886-3901.
PMID: 35441810
PMC: 9582692.
DOI: 10.1002/cam4.4755.
Anaplastic Large Cell Lymphoma: Molecular Pathogenesis and Treatment.
Zhang X, Chien P, Nam S, Heo C
Cancers (Basel). 2022; 14(7).
PMID: 35406421
PMC: 8997054.
DOI: 10.3390/cancers14071650.
Presence of CrkI-containing microvesicles in squamous cell carcinomas could have ramifications on tumor biology and cancer therapeutics.
Mohamed M, Al-Khudari S, Cassini-Vieira P, Erra A, Bagabas R, Houser T
Sci Rep. 2022; 12(1):4803.
PMID: 35314778
PMC: 8938485.
DOI: 10.1038/s41598-022-08905-7.